Nasdaq or NYSE related Biotechnology: Biological Products (No Diagnostic Substances) industry Top Companies List by Market Cap as of August 2026

Nasdaq or NYSE listed Biotechnology: Biological Products (No Diagnostic Substances) industry Top Companies List by Market Cap as of August 2026. Nasdaq and NYSE related Biotechnology: Biological Products (No Diagnostic Substances) industry Largest Companies List by Market Cap as of August 2026

  1. Vir Biotechnology

    World Rank (Aug-2026)
    7,286
    Market Cap (Aug-2026)
    1.564 Billion USD
    World Rank (Jan-05-2024)
    7,125
    Market Cap (Jan-05-2024)
    1.382 Billion USD
    World Rank (Jul-30-2023)
    5,935
    Market Cap (Jul-30-2023)
    1.894 Billion USD
    World Rank (Dec-25-2022)
    3,703
    Market Cap (Dec-25-2022)
    3.425 Billion USD
    World Rank (Jan-07-2022)
    3,617
    Market Cap (Jan-07-2022)
    4.40 Billion USD
    Annual Revenue in USD
    69 Million USD
    Annual Operating Income in USD
    -479 Million USD
    Annual Net Income in USD
    -438 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Vir Biotechnology is a Clinical Stage Immunology company. It is focused on combining immunologic insights with cutting edge technologies to treat and prevent serious infectious diseases. The headquarters is in USA.

    Company Website
    VIR BIOTECHNOLOGY

  2. Novavax

    World Rank (Aug-2026)
    7,980
    Market Cap (Aug-2026)
    1.328 Billion USD
    World Rank (Jan-05-2024)
    11,359
    Market Cap (Jan-05-2024)
    0.613 Billion USD
    World Rank (Jul-30-2023)
    10,617
    Market Cap (Jul-30-2023)
    0.708 Billion USD
    World Rank (Dec-25-2022)
    9,445
    Market Cap (Dec-25-2022)
    0.821 Billion USD
    World Rank (Jan-07-2022)
    1,955
    Market Cap (Jan-07-2022)
    9.58 Billion USD
    Annual Revenue in USD
    1,123 Million USD
    Annual Operating Income in USD
    453 Million USD
    Annual Net Income in USD
    440 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Frankfurt
    Company Profile

    Novavax is a Late Stage Biotechnology company that promotes improved global health through the discovery, development and commercialization of innovative vaccines to prevent serious infectious diseases. The company annual revenue is 157.0 million USD and 375 employees as on 2020. The headquarters is in USA.

    Company Website
    NOVAVAX
    Wikipedia
    Wikipedia

  3. Alvotech

    World Rank (Aug-2026)
    8,192
    Market Cap (Aug-2026)
    1.266 Billion USD
    World Rank (Jan-05-2024)
    4,162
    Market Cap (Jan-05-2024)
    3.219 Billion USD
    World Rank (Jul-30-2023)
    4,793
    Market Cap (Jul-30-2023)
    2.602 Billion USD
    World Rank (Dec-25-2022)
    4,680
    Market Cap (Dec-25-2022)
    2.487 Billion USD
    Headquarters Country
    Iceland
    Yahoo @ Nasdaq
    Company Profile

    The company is a biotechnology company that manufactures biologic medicines like insulin to vaccines to monoclonal antibody cancer therapies, biologic medicines. Headquarters is in Iceland.

    Company Website
    ALVOTECH

  4. Immatics N.V.

    World Rank (Aug-2026)
    8,198
    Market Cap (Aug-2026)
    1.266 Billion USD
    World Rank (Jan-05-2024)
    9,099
    Market Cap (Jan-05-2024)
    0.908 Billion USD
    World Rank (Jul-30-2023)
    8,838
    Market Cap (Jul-30-2023)
    0.980 Billion USD
    World Rank (Dec-25-2022)
    10,806
    Market Cap (Dec-25-2022)
    0.649 Billion USD
    World Rank (Jan-07-2022)
    11,036
    Market Cap (Jan-07-2022)
    0.75 Billion USD
    Headquarters Country
    Germany
    Company Website
    IMMATICS N.V.

  5. MeiraGTx Holdings

    World Rank (Aug-2026)
    8,249
    Market Cap (Aug-2026)
    1.252 Billion USD
    World Rank (Jan-05-2024)
    13,314
    Market Cap (Jan-05-2024)
    0.446 Billion USD
    World Rank (Jul-30-2023)
    14,767
    Market Cap (Jul-30-2023)
    0.362 Billion USD
    World Rank (Dec-25-2022)
    16,414
    Market Cap (Dec-25-2022)
    0.269 Billion USD
    World Rank (Jan-07-2022)
    9,687
    Market Cap (Jan-07-2022)
    0.96 Billion USD
    Annual Revenue in USD
    81 Million USD
    Annual Operating Income in USD
    -106 Million USD
    Annual Net Income in USD
    -114 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    MeiraGTx Holdings is a Clinical Stage Gene Therapy company. It is focused on developing potentially curative treatments for patients living with serious diseases. The company annual revenue is 5.1 million USD and 155 full employees as on 2019. The headquarters is in USA.
    Company Website
    MEIRAGTX HOLDINGS

  6. Solid Biosciences

    World Rank (Aug-2026)
    9,317
    Market Cap (Aug-2026)
    0.986 Billion USD
    World Rank (Jan-05-2024)
    20,729
    Market Cap (Jan-05-2024)
    0.115 Billion USD
    World Rank (Jul-30-2023)
    22,447
    Market Cap (Jul-30-2023)
    0.086 Billion USD
    World Rank (Dec-25-2022)
    21,130
    Market Cap (Dec-25-2022)
    0.110 Billion USD
    World Rank (Jan-07-2022)
    19,806
    Market Cap (Jan-07-2022)
    0.17 Billion USD
    Annual Operating Income in USD
    -179 Million USD
    Annual Net Income in USD
    -174 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Solid Biosciences is a Life Science company focused on developing transformative treatments to improve the lives of patients living with Duchenne muscular dystrophy (Duchenne). The company estimated annual revenue is currently 12.4 million USD per year. The headquarters is in USA.
    Company Website
    SOLID BIOSCIENCES

  7. Kura Oncology

    World Rank (Aug-2026)
    9,405
    Market Cap (Aug-2026)
    0.966 Billion USD
    World Rank (Jan-05-2024)
    7,868
    Market Cap (Jan-05-2024)
    1.161 Billion USD
    World Rank (Jul-30-2023)
    10,368
    Market Cap (Jul-30-2023)
    0.739 Billion USD
    World Rank (Dec-25-2022)
    9,716
    Market Cap (Dec-25-2022)
    0.781 Billion USD
    World Rank (Jan-07-2022)
    10,231
    Market Cap (Jan-07-2022)
    0.86 Billion USD
    Annual Revenue in USD
    67 Million USD
    Annual Operating Income in USD
    -304 Million USD
    Annual Net Income in USD
    -279 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Kura Oncology is a Clinical Stage Biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company total assets is 265.6 million USD and 134 employees as on 2019. The headquarters is in USA.
    Company Website
    KURA ONCOLOGY

Share